Shares of Baxter International (BAX) have gained 2.4% in the first seven trading sessions in July after declining 13.5% in the first six months of 2024.The decline in BAX’s shares during the first half can be attributed to challenges, including inflationary pressure and weaker ESRD patient volume in China due to the residual impact of COVID-19. Moreover, China’s value-based procurement initiatives are lowering realized price for the company’s products in the country.Meanwhile, the recovery in Baxter’s share ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true v ...

Shares of Baxter International (BAX) have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation System. Though the share price had declined following the news, it recovered following reports of potential discussion on divestment of BAX’s kidney care segment.The device, a portable ventilator for patients suffering from chronic respiratory failure or other breathing issues, has been recalled by Baxter. The recall follows the detection of damaged battery charger dongles, ...

Core Insights - Zacks Premium provides tools for investors to enhance their stock market engagement and confidence through various research services [1] Zacks Style Scores - Zacks Style Scores rate stocks based on value, growth, and momentum characteristics, helping investors identify securities likely to outperform the market in the short term [2] - Each stock is assigned a rating from A to F, with A indicating the highest potential for outperformance [2] Value Score - The Value Style Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [2] Growth Score - The Growth Style Score assesses a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow [3] Momentum Score - The Momentum Style Score evaluates stocks based on price trends and earnings estimate changes, aiding investors in timing their purchases of high-momentum stocks [3] VGM Score - The VGM Score combines the Value, Growth, and Momentum Scores to identify stocks with the best overall potential [4] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to help investors build successful portfolios, with 1 (Strong Buy) stocks yielding an average annual return of +25.41% since 1988 [5] - There are over 800 stocks rated 1 or 2, which can be overwhelming for investors [5] Stock to Watch: Baxter International (BAX) - Baxter International Inc. is a global medical technology company with a presence in over 100 countries, focusing on products and digital health solutions for healthcare organizations [7] - BAX currently holds a 3 (Hold) rating on the Zacks Rank and has a VGM Score of A, indicating strong potential [7] - The company has a Value Style Score of A, supported by a forward P/E ratio of 11.4, making it attractive to value investors [7] - Analysts have recently revised BAX's earnings estimate upwards, with the Zacks Consensus Estimate increasing by $0.02 to $2.91 per share for fiscal 2024 [7]

Baxter International (BAX) is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 12.4% year to date against the industry's 3.1% growth. The S&P 500 Index has increased 11.6% in the same time frame.BAX, with a market capitalization of $17.27 billion, is a global medical technology company providing items such as kidney-dialysis equipment, infusio ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores.What are t ...

Baxter International Inc. (BAX) recently received the FDA’s approval for an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid, which provides calories and essential fatty acids for parenteral nutrition, is currently available to order in the United States.Clinolipid has been available in the United States for adults since 2019 and is now available for use in all ages.The latest regulatory clearance is expected to ...

Baxter International (BAX) reported $3.59 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 1.6%. EPS of $0.65 for the same period compares to $0.59 a year ago.The reported revenue represents a surprise of +1.20% over the Zacks Consensus Estimate of $3.55 billion. With the consensus EPS estimate being $0.61, the EPS surprise was +6.56%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to deter ...

FI RS T-Q UA RT ER 2024 EA RNI NGS Baxter International Inc. May 2, 2024 1 FORWA R D- LOOKING STAT EM ENT S ...

Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Clare Trachtman - Vice President, Investor Relations Joe Almeida - Chairman & Chief Executive Officer Joel Grade - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Pito Chickering - Deutsche Bank Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Danielle Antalffy - UBS Patrick Wood - Morgan Stanley Travis Steed - Bank of America ...